» Articles » PMID: 28095042

GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE

Overview
Journal Endocr Pract
Specialty Endocrinology
Date 2017 Jan 18
PMID 28095042
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Increasing emphasis is being placed on appropriateness of care and avoidance of over- and under-treatment. Indeterminate thyroid nodules (ITNs) present a particular risk for this problem because cancer found via diagnostic lobectomy (DL) often requires a completion thyroidectomy (CT). However, initial total thyroidectomy (TT) for benign ITN results in lifelong thyroid hormone replacement. We sought to measure the accuracy and factors associated with the extent of initial thyroidectomy for ITN.

Methods: We queried a single institution thyroid surgery database for all adult patients undergoing an initial operation for ITN. Multivariate logistic regression identified factors associated with either oncologic under- or overtreatment at initial operation.

Results: There were 639 patients with ITN. The median age was 52 (range, 18 to 93) years, 78.4% were female, and final pathology revealed a cancer >1 cm in 24.7%. The most common cytology was follicular neoplasm (45.1%) followed by Hürthle cell neoplasm (20.2%). CT or initial oncologic undertreatment was required in 58 patients (9.3%). Excluding those with goiters, 19.0% were treated with TT for benign final pathology. Multivariate analysis failed to identify any factor that independently predicted the need for CT. Female gender was associated with TT in benign disease (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.0 to 4.5; P = .05). Age >45 years predicted correct initial use of DL (OR, 2.6; 95% CI, 1.2 to 5.7; P = .02). Suspicious for papillary thyroid carcinoma (OR, 5.7; 95% CI, 2.1 to 15.3; P<.01) and frozen section (OR, 9.7; 95% CI, 2.5 to 38.6; P<.01) were associated with oncologically appropriate initial TT. The highest frequency of CT occurred in patients with follicular lesion of undetermined significance (11.6%). TT for benign final pathology occurred most frequently in patients with a Hürthle cell neoplasm (24.8%).

Conclusion: In patients with ITN, nearly 30% received an inappropriate extent of initial thyroidectomy from an oncologic standpoint. Tools to pre-operatively identify both benign and malignant disease can assist in the complex decision making to gauge the proper extent of initial surgery for ITN.

Abbreviations: ATA = American Thyroid Association AUS = atypia of undetermined significance CI = confidence interval CT = completion thyroidectomy FLUS = follicular lesion of undetermined significance ITN = indeterminate thyroid nodule OR = odds ratio PTC = papillary thyroid carcinoma TT = total thyroidectomy.

Citing Articles

Completion Thyroidectomy Trends and Rates: A Systematic Review and Meta-Analysis.

Soibelman D, Ronen O Clin Otolaryngol. 2024; 50(2):205-219.

PMID: 39587912 PMC: 11792430. DOI: 10.1111/coa.14262.


Management of follicular thyroid carcinoma.

Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M Eur Thyroid J. 2024; 13(5).

PMID: 39419099 PMC: 11558955. DOI: 10.1530/ETJ-24-0146.


Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.

Chan W, Chiang P, Lin A, Chang Y, Lin W Ultrasonography. 2024; 43(6):395-406.

PMID: 39397446 PMC: 11532522. DOI: 10.14366/usg.24083.


Detection of RAS p.Q61R by Immunohistochemistry in Practice: A Clinicopathologic Study of 217 Thyroid Nodules with Molecular Correlates.

Alzumaili B, Fisch A, Faquin W, Nose V, Randolph G, Sadow P Endocr Pathol. 2024; 35(3):219-229.

PMID: 39096324 DOI: 10.1007/s12022-024-09821-4.


Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region.

Loderer T, Bonati E, Donato V, Viani L, Cozzani F, Del Rio P Gland Surg. 2023; 12(7):884-893.

PMID: 37727346 PMC: 10506119. DOI: 10.21037/gs-22-491.


References
1.
Alexander E, Kennedy G, Baloch Z, Cibas E, Chudova D, Diggans J . Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012; 367(8):705-15. DOI: 10.1056/NEJMoa1203208. View

2.
Wu J, Lam R, Levin M, Rao J, Sullivan P, Yeh M . Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules. Surgery. 2015; 159(1):118-26. DOI: 10.1016/j.surg.2015.05.035. View

3.
Khoncarly S, Tamarkin S, McHenry C . Can ultrasound be used to predict malignancy in patients with a thyroid nodule and an indeterminate fine-needle aspiration biopsy?. Surgery. 2014; 156(4):967-70. DOI: 10.1016/j.surg.2014.06.043. View

4.
Maia F, Matos P, Pavin E, Vassallo J, Zantut-Wittmann D . Value of ultrasound and cytological classification system to predict the malignancy of thyroid nodules with indeterminate cytology. Endocr Pathol. 2011; 22(2):66-73. DOI: 10.1007/s12022-011-9159-6. View

5.
Ferris R, Baloch Z, Bernet V, Chen A, Fahey 3rd T, Ganly I . American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid. 2015; 25(7):760-8. PMC: 4519104. DOI: 10.1089/thy.2014.0502. View